The Automation Partnership (TAP) will showcase its Advanced Micro Bioreactor System (AMBR) at Cell Line Development and Engineering 2010, to take place 25-26 February in San Francisco, the US.
AMBR replicates the characteristics of classical bioreactors at microscale (10 - 15ml working volume) by using cost-effective, disposable micro bioreactors controlled by an automated workstation.
It enables the rapid evaluation of multiple bioreactor cultures (24in parallel), improving productivity in cell-line development with significant savings on materials and labour.
During the conference, Dr Richard Wales, TAP's technology director for AMBR, will present data from independent trials of CHO cells expressing an antibody construct.
This includes data from testing carried out at major biotechnology companies.
The testing will feature comparisons with five- and 10-litre bioreactors and will demonstrate the potential of AMBR as a cost-effective route for cell-line selection and early process development.
The system will also be premiered a week later at a Cell Line Development and Engineering 2010 event that will take place 1-5 March in Prague, Czech Republic.
